Biogen's head of neurodegeneration leaves

[cafead]

via Samantha Budd Haeberlein, one of the key leaders behind development of Biogen’s Alzheimer’s disease med Aduhelm, is leaving after eight years. She served as head of the Neurodegeneration Development Unit, which lists Aduhelm as its most famous—or infamous—products.

article source